Jan Mattsson, Chief Scientific Officer at ALBIREO PHARMA, INC. (ALBO), sold 6,176 shares at $43.80 ($271K) on 2023-01-19, disclosed to the SEC on 2023-01-20.
Open-market sale of $271k ALBO by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.80 | 3,088 | $135K | 50.0% |
| 2 | $43.80 | 3,088 | $135K | 50.0% |
| Total | $43.80 avg | 6,176 | $271K | 100% |
| Filing → |
| ALBO | SELL | 2022-07-25 | $5K | — | Filing → |
| ALBO | SELL | 2022-04-25 | $7K | — | Filing → |
| ALBO | SELL | 2022-01-25 | $20K | — | Filing → |